Nice thread:
NOX - going to clinic early 2017 - testing in late stage cancer patients a most potent derivative of the isoflavone family - via a novel delivery method. Looking to sensitise tumours to chemo in these terminal patients. Fantastic stuff.
PNV - still digging on this one, hoping to be fully knowledgeable before earnings from US operations hit market.
